222 related articles for article (PubMed ID: 30678417)
1. [The clinical and pathological features, biomarker characteristics and prognosis analysis of lung adenosquamous carcinoma].
Zhou SY; Xue Q; Ying JM; Hu XS; Yang JL; Lin H; Shi YK
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):50-55. PubMed ID: 30678417
[No Abstract] [Full Text] [Related]
2. [The efficacy and influence factors analysis of EGFR TKIs on patients with lung adenosquamous carcinoma].
Zhou SY; Hu XS; Li JL; Wang Y; Liu YT; Xing PY; Yang JL; Lin H; Shi YK
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):776-781. PubMed ID: 30392343
[No Abstract] [Full Text] [Related]
3. [Clinicopathologic Features and Prognostic Implications in 72 Cases
with Lung Adenosquamous Carcinoma].
Wu X; Li J; Chen S; Yu L; Yang B
Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):653-658. PubMed ID: 27760593
[TBL] [Abstract][Full Text] [Related]
4. Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung.
Kang SM; Kang HJ; Shin JH; Kim H; Shin DH; Kim SK; Kim JH; Chung KY; Kim SK; Chang J
Cancer; 2007 Feb; 109(3):581-7. PubMed ID: 17186532
[TBL] [Abstract][Full Text] [Related]
5. Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods.
Shi X; Wu H; Lu J; Duan H; Liu X; Liang Z
Sci Rep; 2016 Feb; 6():22297. PubMed ID: 26923333
[TBL] [Abstract][Full Text] [Related]
6. The adenosquamous lung carcinoma: clinical and pathological characteristics.
Hofmann HS; Knolle J; Neef H
J Cardiovasc Surg (Torino); 1994 Dec; 35(6):543-7. PubMed ID: 7698972
[TBL] [Abstract][Full Text] [Related]
7. [Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Fang F; Wang YX; Hu ST; Yang L; Di J; Liu DG; Lyu N
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):432-437. PubMed ID: 29886587
[No Abstract] [Full Text] [Related]
8. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
9. A clinicopathologic study of the resected cases of adenosquamous carcinoma of the lung.
Kamiyoshihara M; Hirai T; Kawashima O; Ishikawa S; Morishita Y; Maeshima A
Oncol Rep; 1998; 5(4):861-5. PubMed ID: 9625833
[TBL] [Abstract][Full Text] [Related]
10. Adenosquamous carcinoma of the lung. Surgical results compared with squamous cell and adenocarcinoma.
Hsia JY; Chen CY; Hsu CP; Shai SE; Wang PY
Scand Cardiovasc J; 1999; 33(1):29-32. PubMed ID: 10093856
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Clinical Profile of EGFR Mutation In Non- Small-Cell Lung Carcinoma Patients in Southwest China.
Zhou J; Song XB; He H; Zhou Y; Lu XJ; Ying BW
Asian Pac J Cancer Prev; 2016; 17(3):965-71. PubMed ID: 27039821
[TBL] [Abstract][Full Text] [Related]
12. Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene.
Krawczyk P; Kowalski DM; Krawczyk KW; Szczyrek M; Mlak R; Rolski A; Szudy A; Kieszko R; Winiarczyk K; Milanowski J; Krzakowski M
Oncol Rep; 2013 Sep; 30(3):1463-72. PubMed ID: 23783797
[TBL] [Abstract][Full Text] [Related]
13. Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma.
Zhi Q; Wang Y; Wang X; Yue D; Li K; Jiang R
Oncotarget; 2016 Oct; 7(40):64798-64809. PubMed ID: 27623437
[TBL] [Abstract][Full Text] [Related]
14. Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung.
Nakagawa K; Yasumitu T; Fukuhara K; Shiono H; Kikui M
Ann Thorac Surg; 2003 Jun; 75(6):1740-4. PubMed ID: 12822609
[TBL] [Abstract][Full Text] [Related]
15. Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases.
Maeda H; Matsumura A; Kawabata T; Suito T; Kawashima O; Watanabe T; Okabayashi K; Kubota I;
Eur J Cardiothorac Surg; 2012 Feb; 41(2):357-61. PubMed ID: 21737295
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung.
Shiozawa T; Ishii G; Goto K; Nagai K; Mimaki S; Ono S; Niho S; Fujii S; Ohe Y; Tsuchihara K; Ochiai A
Pathol Int; 2013 Feb; 63(2):77-84. PubMed ID: 23464964
[TBL] [Abstract][Full Text] [Related]
17. Adenosquamous and squamous carcinoma of the colon and upper rectum: a clinical and histopathologic study.
Frizelle FA; Hobday KS; Batts KP; Nelson H
Dis Colon Rectum; 2001 Mar; 44(3):341-6. PubMed ID: 11289278
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients.
Gejman R; González S; Muñoz-Medel M; Nervi B; Sánchez C; Ibáñez C; Peña J; Madrid J; Briones J; Pérez P; Garrido M; Galindo H
Asian Pac J Cancer Prev; 2019 Jan; 20(1):1-4. PubMed ID: 30677862
[TBL] [Abstract][Full Text] [Related]
20. MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.
Song Z; Wang X; Zheng Y; Su H; Zhang Y
Clin Lung Cancer; 2017 Mar; 18(2):213-219.e2. PubMed ID: 28322191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
